ESC 365 - Outcome evaluation of the association of sacubitril/valsartan and iSGLT2 in diabetic patients with heart failure with reduced ejection fraction.

HFA Premium Access

Outcome evaluation of the association of sacubitril/valsartan and iSGLT2 in diabetic patients with heart failure with reduced ejection fraction.

Session: Poster session 1 - Basic Science - Chronic Heart Failure – Treatment

Topic: Pharmacotherapy

Speaker: Doctor F. Camacho Jurado (Puerto Real, ES)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Doctor Francisco Javier Camacho Jurado

Puerto Real Hospital, Puerto Real (Spain)

0 follower

13 more presentations in this session

Elamipretide restores protein and mRNA expression levels of S100A1 in left ventricular myocardium of dogs with chronic heart failure

Speaker: Professor H. Sabbah (Detroit, US)

Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats

Speaker: Miss M. Krasnova (Saint Petersburg, RU)

Introducing SGLT2 inhibitors during hospitalization. Safety and outocmes.

Speaker: Doctor F. Camacho Jurado (Puerto Real, ES)

Outcome evaluation of Sacubitril/Valsartan in patients with Heart Failure and reduced ejection fraction with regular follow-up meetings in a Spanish heart failure day-hospital.

Speaker: Doctor F. Camacho Jurado (Puerto Real, ES)

Effects of irbesartan for renal failure in the patients with chronic heart failure and preserved systolic function and atrial fibrillation

Access the full session

Poster session 1 - Basic Science - Chronic Heart Failure – Treatment

Speakers: Doctor F. Camacho Jurado, Professor H. Sabbah, Miss M. Krasnova, Doctor F. Camacho Jurado, Doctor F. Camacho Jurado

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources